Oxedrine; p-Synephrine; Parasympatol; Sympaethamine; Sympatol; Sympaethamin; Analeptin; Simpatol; Simpalon; Synephrin; Synthenate; (+/-)-Synephrine; Sympathol; p-Oxedrine; 4-(1-Hydroxy-2-(methylamino)ethyl)phenol; Ethaphene; DL-SYNEPHRINE; 4-[1-Hydroxy-2-(methylamino)ethyl]phenol; Synefrin; 1-(4-Hydroxyphenyl)-N-methylethanolamine; 1-(4-Hydroxyphenyl)-2-methylaminoethanol; NSC 166285; (RS)-1-(4-Hydroxyphenyl)-2-(methylamino)ethanol; Synephrine (racemate); S 38537-9; 94-07-5 (racemate); NSC166285; 1-(4-Hydroxyphenyl)-(2-methylamino)ethanol; WLN: QR DYQ1M1; DSSTox_CID_10588; DSSTox_RID_78850; Synefrin [Czech]; DSSTox_GSID_30588; Pentedrin [German]; (R,S)-1-(4-Hydroxyphenyl)-2-(methylamino)ethanol; p-((Methylamino)ethanol)phenol; p-[(Methylamino)ethanol]phenol; Parakorper [German]; 1-(4-Hydroxyphenyl)-2-(methylamino)ethanol; Parakorper; p-Hydroxyphenyl(methylamino)ethanol; p-Methylaminoethanolphenol; 1-[4-Hydroxyphenyl]-2-methylaminoethanol; SMR000059111; 1-(4-Hydroxyphenyl)-(N-methylethanol)amine; p-Hydroxyphenylmethylaminoethanol; 1-(4-hydroxyphenyl)-2-(methylamino)ethan-1-ol; Oxedrine [INN:BAN]; 4-Hydroxy-alpha-(methylaminomethyl)benzyl alcohol; ((Methylamino)methyl)((4-hydroxyphenyl)carbinol); [(Methylamino)methyl][(4-hydroxyphenyl)carbinol]; SR-01000002983; EINECS 202-300-9; (+-)-N-Methyloctopamine; Methylaminomethyl(4-hydroxyphenyl)carbinol; MFCD00002370; (y)-Synephrine; Synephrine,(S); NCGC00016351-01; (?)-Synephrine; Oxedrine (BAN); (+/-)synephrine; (+,-)-Synephrine; NSC 170956; Synephrine (Oxedrine); Synephrine - Oxedrine; Prestwick0_001088; Prestwick1_001088; Prestwick2_001088; Prestwick3_001088; (.+/-.)-Synephrine; Lopac0_001085; BSPBio_001136; MLS000069435; MLS001424216; CHEMBL33720; SCHEMBL146500; SPBio_003028; Synephrine, analytical standard; (.+/-.)-N-Methyloctopamine; BPBio1_001250; DTXSID0030588; CTK2F4574; (+/-)-Synephrine, >=98%; HMS1571I18; HMS2052G09; HMS2098I18; HMS2233F20; HMS3263I12; HMS3264E11; HMS3369C13; HMS3394G09; HMS3656O09; HMS3715I18; HMS3884D15; Pharmakon1600-01506085; ALBB-025740; HY-N0132; Tox21_110390; Tox21_200962; Tox21_501085; BBL015111; BDBM50102660; CS0043; NSC170956; NSC759316; PDSP1_000167; PDSP2_000166; s2362; SBB063601; STK803113; AKOS004119915; AKOS016038542; Tox21_110390_1; CCG-101098; CCG-205162; DB09203; KS-5152; LP01085; MCULE-4991429316; NC00348; NSC-166285; NSC-170956; NSC-759316; SDCCGSBI-0051055.P003; NCGC00015924-03; NCGC00015924-04; NCGC00015924-05; NCGC00015924-06; NCGC00015924-08; NCGC00015924-09; NCGC00015924-12; NCGC00015924-13; NCGC00015924-25; NCGC00089788-02; NCGC00089788-03; NCGC00089788-04; NCGC00258515-01; NCGC00261770-01; (+)-[(methylamino)methyl]-Benzenemethano; BP-12742; SC-46736; ST095769; SBI-0051055.P002; AB0014348; AB00514040; CS-0007857; EU-0101085; FT-0618685; FT-0653012; N1706; S0232; SW197214-5; T5534; 4-[1-Hydroxy-2-(methylamino)ethyl]phenol #; 4-Hydroxy-a-(methylaminomethyl)benzyl alcohol; 94S075; C04548; D07148; S 0752; AB00384265_11; Q421351; Q-100668; SR-01000002983-3; SR-01000002983-7; SR-01000002983-8; W-100214; 7336264B-EDC9-42C5-939B-FF800AB5BB4A; Oxedrine; 4-Hydroxy-a-[(methylamino)methyl]-benzenemethanol